Stereotaxis (STXS) Notes Payables (2020 - 2021)
Stereotaxis' (STXS) quarterly Notes Payables came in at $1.9 million in Q1 2021, up 61.57% quarter-over-quarter from $1.2 million in Q4 2020.
Analysis
Stereotaxis (STXS) Notes Payables (2020 - 2021) Analysis & Trends
Stereotaxis (STXS) has reported Notes Payables for 2 consecutive years, with $1.9 million the latest figure, recorded in Q1 2021.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.9 million in Q1 2021; TTM through Mar 2021 was $1.9 million, a N/A change from a year earlier, with the FY2020 full-year figure at $1.2 million, changed N/A from the prior year.
- Notes Payables was $1.9 million for Q1 2021 at Stereotaxis, up from $1.2 million in the prior quarter.
- Over five years, Notes Payables peaked at $2.2 million in Q2 2020 and troughed at $457244.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1.91 Mn |
| Dec 31, 2020 | 1.19 Mn |
| Sep 30, 2020 | 457,244.00 |
| Jun 30, 2020 | 2.16 Mn |